Literature DB >> 19075173

Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.

Ana L Gleisner1, Michael A Choti, Lia Assumpcao, Hari Nathan, Richard D Schulick, Timothy M Pawlik.   

Abstract

HYPOTHESIS: Although radiofrequency ablation (RFA) is increasingly an accepted option for patients with colorectal liver metastases, patients treated with resection vs RFA may have different tumor biology profiles, which might confound the relationship between choice of liver-directed therapy and outcome.
DESIGN: Retrospective review of a prospectively collected database.
SETTING: Major hepatobiliary center. PATIENTS: Between January 1, 1999, and August 30, 2006, 258 patients with colorectal liver metastases underwent hepatic resection with or without RFA. MAIN OUTCOME MEASURES: Evaluation of outcome following resection alone, combined resection-RFA, and RFA alone using 3 statistical methods (paired-match control, Cox proportional hazards multivariate model, and propensity index) to identify and adjust for potential confounding variables.
RESULTS: The median number of hepatic lesions was 2, and the median size of the largest lesion was 3.0 cm. One hundred ninety-two patients (74.4%) underwent resection alone, 55 patients (21.3%) underwent resection-RFA, and 11 patients (4.3%) underwent RFA alone. Patients who underwent resection-RFA had significantly increased risk of extrahepatic failure at 1 year vs patients who underwent resection alone or RFA alone (P < .05). On matched control and multivariate analyses, patients who underwent RFA with or without resection had significantly worse disease-free and overall survival than patients who underwent resection alone. Propensity score methods revealed that the aggregate distribution of clinical risk factors for resection-RFA was markedly different from that for resection alone. This suggested a lack of comparability to allow for statistical comparisons in the assessment of causal inferences regarding the efficacy of RFA therapy.
CONCLUSION: Although results of matched control and multivariate analyses suggested that RFA with or without resection was associated with worse outcome, propensity score methods revealed that the resection-RFA and resection-alone groups were different with regard to baseline tumor and treatment-related factors, making causal inferences about the efficacy of RFA unreliable.

Entities:  

Mesh:

Year:  2008        PMID: 19075173     DOI: 10.1001/archsurg.143.12.1204

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  51 in total

1.  Treatment of colorectal cancer with unresectable synchronous liver-only metastases with combined therapeutic modalities.

Authors:  Yunlong Cui; Huikai Li; Qiang Wu; Ti Zhang; Dalu Kong; Tianqiang Song; Tao Ru; Ping Chen; Qiang Li
Journal:  J Gastrointest Surg       Date:  2010-10-05       Impact factor: 3.452

2.  The Results of the Combine Treatment of Patients with Liver Bilobar Metastases from Colorectal Cancer Using Radiofrequency Ablation.

Authors:  Oleg Igorevich Kaganov; Sergei Vasilevich Kozlov; Andrei Evgenyevich Orlov; Nikita Vyacheslavovich Blinov
Journal:  Indian J Surg Oncol       Date:  2018-04-09

3.  Current strategies in interventional oncology of colorectal liver metastases.

Authors:  Tatjana Gruber-Rouh; Christian Marko; Axel Thalhammer; Nour-Eldin Nour-Eldin; Marcel Langenbach; Martin Beeres; Nagy N Naguib; Stephan Zangos; Thomas J Vogl
Journal:  Br J Radiol       Date:  2016-05-26       Impact factor: 3.039

4.  Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.

Authors:  Georgios Antonios Margonis; Yuhree Kim; Gaya Spolverato; Aslam Ejaz; Rohan Gupta; David Cosgrove; Robert Anders; Georgios Karagkounis; Michael A Choti; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2015-08       Impact factor: 14.766

5.  Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study.

Authors:  Susan Tsai; Michael A Choti; Lia Assumpcao; John L Cameron; Ana L Gleisner; Joseph M Herman; Frederic Eckhauser; Barish H Edil; Richard D Schulick; Christopher L Wolfgang; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2010-04-30       Impact factor: 3.452

6.  Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.

Authors:  Kiyohiko Omichi; Junichi Shindoh; Jordan M Cloyd; Takashi Mizuno; Yun Shin Chun; Claudius Conrad; Thomas A Aloia; Ching-Wei D Tzeng; Jean-Nicolas Vauthey
Journal:  Eur J Surg Oncol       Date:  2017-11-24       Impact factor: 4.424

7.  Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis.

Authors:  Yun-Zi Wu; Bin Li; Tao Wang; Shuang-Jia Wang; Yan-Ming Zhou
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

Review 8.  Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.

Authors:  Skye C Mayo; Joseph M Herman; David Cosgrove; Nik Bhagat; Ihab Kamel; Jean-Francois H Geschwind; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2012-10-11       Impact factor: 6.113

9.  Management of potentially resectable colorectal cancer liver metastases.

Authors:  Fausto Meriggi; Paola Bertocchi; Alberto Zaniboni
Journal:  World J Gastrointest Surg       Date:  2013-05-27

10.  Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases.

Authors:  Nan He; Qian-Na Jin; Di Wang; Yi-Ming Yang; Yu-Lin Liu; Guo-Bin Wang; Kai-Xiong Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.